Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(0.55)
# 3,767
Out of 4,814 analysts
308
Total ratings
15.61%
Success rate
-36.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNAZ TransCode Therapeutics | Maintains: Buy | $20 → $10 | $0.27 | +3,569.72% | 17 | Apr 16, 2025 | |
| VTVT vTv Therapeutics | Initiates: Buy | $36 | $19.70 | +82.74% | 1 | Apr 9, 2025 | |
| CNTB Connect Biopharma Holdings | Reiterates: Buy | $8 | $0.77 | +938.96% | 6 | Apr 1, 2025 | |
| IOBT IO Biotech | Reiterates: Buy | $12 | $0.86 | +1,295.35% | 13 | Apr 1, 2025 | |
| GNLX Genelux | Reiterates: Buy | $30 | $2.46 | +1,119.51% | 7 | Mar 31, 2025 | |
| FEMY Femasys | Reiterates: Buy | $15 | $1.24 | +1,109.68% | 21 | Mar 28, 2025 | |
| ACRV Acrivon Therapeutics | Reiterates: Buy | $19 | $1.81 | +949.72% | 12 | Mar 28, 2025 | |
| NKTX Nkarta | Reiterates: Buy | $18 | $1.72 | +946.51% | 15 | Mar 27, 2025 | |
| IMNN Imunon | Reiterates: Buy | $14 | $0.85 | +1,547.06% | 12 | Mar 26, 2025 | |
| ATOS Atossa Therapeutics | Reiterates: Buy | $7 | $0.62 | +1,027.03% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.85 | +488.93% | 11 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.26 | +604.23% | 19 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $7.27 | +381.43% | 12 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.08 | - | 15 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.64 | +570.73% | 10 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.34 | +787.57% | 8 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.27 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $3.97 | +907.56% | 9 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $22 | $20.58 | +6.90% | 8 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $7.90 | +203.99% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $58 | $27.66 | +109.69% | 1 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.45 | +3,900.00% | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $32 | $4.40 | +627.27% | 13 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.08 | - | 15 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $15.56 | +144.22% | 18 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $6 | $2.20 | +172.73% | 13 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $61.99 | +85.51% | 12 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $2.75 | +1,100.00% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.48 | - | 1 | Apr 25, 2024 |
TransCode Therapeutics
Apr 16, 2025
Maintains: Buy
Price Target: $20 → $10
Current: $0.27
Upside: +3,569.72%
vTv Therapeutics
Apr 9, 2025
Initiates: Buy
Price Target: $36
Current: $19.70
Upside: +82.74%
Connect Biopharma Holdings
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $0.77
Upside: +938.96%
IO Biotech
Apr 1, 2025
Reiterates: Buy
Price Target: $12
Current: $0.86
Upside: +1,295.35%
Genelux
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $2.46
Upside: +1,119.51%
Femasys
Mar 28, 2025
Reiterates: Buy
Price Target: $15
Current: $1.24
Upside: +1,109.68%
Acrivon Therapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $1.81
Upside: +949.72%
Nkarta
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $1.72
Upside: +946.51%
Imunon
Mar 26, 2025
Reiterates: Buy
Price Target: $14
Current: $0.85
Upside: +1,547.06%
Atossa Therapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $0.62
Upside: +1,027.03%
Mar 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.85
Upside: +488.93%
Mar 19, 2025
Reiterates: Buy
Price Target: $30
Current: $4.26
Upside: +604.23%
Mar 18, 2025
Reiterates: Buy
Price Target: $35
Current: $7.27
Upside: +381.43%
Mar 18, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.08
Upside: -
Mar 18, 2025
Reiterates: Buy
Price Target: $11
Current: $1.64
Upside: +570.73%
Mar 17, 2025
Reiterates: Buy
Price Target: $3
Current: $0.34
Upside: +787.57%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.27
Upside: -
Mar 11, 2025
Reiterates: Buy
Price Target: $40
Current: $3.97
Upside: +907.56%
Mar 4, 2025
Reiterates: Neutral
Price Target: $22
Current: $20.58
Upside: +6.90%
Feb 26, 2025
Upgrades: Buy
Price Target: $24
Current: $7.90
Upside: +203.99%
Feb 24, 2025
Reiterates: Buy
Price Target: $58
Current: $27.66
Upside: +109.69%
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $0.45
Upside: +3,900.00%
Feb 3, 2025
Maintains: Buy
Price Target: $15 → $32
Current: $4.40
Upside: +627.27%
Jan 14, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.08
Upside: -
Jan 14, 2025
Reiterates: Buy
Price Target: $38
Current: $15.56
Upside: +144.22%
Jan 7, 2025
Maintains: Neutral
Price Target: $8 → $6
Current: $2.20
Upside: +172.73%
Dec 10, 2024
Reiterates: Buy
Price Target: $115
Current: $61.99
Upside: +85.51%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $2.75
Upside: +1,100.00%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.48
Upside: -